China Medicaments of ceftazidime, neither in measured doses nor in retail packings (HS 30032012) Imports by Country

Monthly USD Source: GACC Data as of: 2022-08 Coverage 2021-01–2022-08

Total imports $174.1K
Latest value $146.2K
Partners 1
Coverage 2021-01 to 2022-08

Showing all published months. Partner preview tables include up to 20 countries.

Monthly Import Trend

USD value by month, all available partner countries combined

Monthly chart is available through the data API.
Open data API

Free partner preview shows up to 20 countries.

Source
GACC statistics query
Unit
USD
Rows
Loading...
Data as of
2022-08

Partner Preview by Origin Country

Total value across the selected data period

Partner Value Share
South Korea $151.3K 86.9%
India $22.8K 13.1%

Latest Month Partner Ranking

Availability is confirmed when the API response loads.

Partner Value Share
South Korea $146.2K 100.0%

Annual Totals

Year Import value
2021 $22.8K
2022 $151.3K

Public data shows up to 20 partner countries for this exact eight-digit customs code. Request all available partner-month rows in CSV or Excel.

Data notes

HS 30032012 is also written 3003.20.12. Values are in USD; the public series does not report tonnes or kg. Product scope: Institutional or bulk-quantity medicines utilizing ceftazidime as the active antibiotic component are traded without measured retail packaging. The public page shows monthly import partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.

Source

Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.

Citation

China Data Portal. "China Medicaments of ceftazidime, neither in measured doses nor in retail packings (HS 30032012) Import Data." https://chinadata.live/china-trade/hs8/30032012/

Data notes

HS 30032012 is also written 3003.20.12. Values are in USD; the public series does not report tonnes or kg. Product scope: Institutional or bulk-quantity medicines utilizing ceftazidime as the active antibiotic component are traded without measured retail packaging. The public page shows monthly import partner previews from official GACC customs statistics. Full partner-month rows are available through a scoped custom data request.

Source

Source: China General Administration of Customs (GACC), cleaned and structured by China Data Portal.
Transformations: Values are presented as published by the source.

Citation

China Data Portal. "China Medicaments of ceftazidime, neither in measured doses nor in retail packings (HS 30032012) Import Data." https://chinadata.live/china-trade/hs8/30032012/

About this data

How much medicaments of ceftazidime, neither in measured doses nor in retail packings does China import?

China imported $174K of medicaments of ceftazidime, neither in measured doses nor in retail packings in the 3 months to August 2022, averaging $58.0K per month, based on official China customs statistics (HS 30032012).

What products are covered by HS 30032012?

Institutional or bulk-quantity medicines utilizing ceftazidime as the active antibiotic component are traded without measured retail packaging.

Which countries supply the most medicaments of ceftazidime, neither in measured doses nor in retail packings to China?

South Korea and India together account for 100% of the published total.

Where does this China customs data come from, and can I get the full dataset?

Figures come from official China General Administration of Customs (GACC) statistics, published monthly. ChinaData cleans partner names, periods and values so the series is ready for analysis. Partner-level rows for every month, including HS8 detail, are available on request.

Browse PharmaceuticalsCompare this product with chapter-level exports and imports. Product trade data directoryBrowse loaded and requestable China product trade data pages. Trade by countryExplore China bilateral trade data by partner and HS chapter.
💬 Need trade data?